Inside FDA approval of new drug to slow Alzheimer’s disease

Alzheimer’s Association expert discusses significance, challenges of breakthrough medicine.
Updated: Jun. 8, 2021 at 4:49 PM MDT
Email This Link
Share on Pinterest
Share on LinkedIn

COLORADO SPRINGS, Colo. (KKTV) - 11 News digital anchor Jon Wiener talked in-depth with Jim Herlihy of the Alzheimer’s Association Denver office about the recent Alzheimer’s drug approved by the FDA.

Government health officials have approved the first drug that they say may help slow Alzheimer’s disease. The surprise decision came after the agency’s independent advisers said the treatment hadn’t been shown to help treat the brain-destroying disease. The Food and Drug Administration is not required to follow their advice. The agency approved the infused drug from Biogen. It’s the first new Alzheimer’s treatment in nearly 20 years and the only one that FDA has backed to treat the underlying disease, rather than manage symptoms.

Copyright 2021 KKTV. All rights reserved.